CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript
Operator: Good day and welcome to the CorMedix Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Cormedix Inc. (CRMD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Elliott Management Paul Singer | 1,550,523 | $12,528,226 | 0.06% | |
| 2. | D E Shaw D. E. Shaw | 320,989 | $2,593,591 | +147% | 0% |
| 3. | 204,700 | $1,653,976 | +109% | 0% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 161,755 | $1,306,981 | +7% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 126,596 | $1,022,896 | +234% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.74 | 13,561 | 352,839 | 2024-03-13 | Filing | ||
| $3.30 | 3,000 | 15,250 | 2023-12-15 | Filing | ||
| $3.45 | 3,000 | 12,250 | 2023-12-14 | Filing | ||
| $4.00 | 1,000 | 4,900 | 2023-11-17 | Filing | ||
| $3.71 | 10,000 | 219,726 | 2023-09-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.18 | 140,027 | 45,397 | 2024-11-14 | Filing | ||
| $6.92 | 8,000 | Officer | 0 | 2021-05-21 | Filing | |
| $2.00 | 10,000 | Officer | 0 | 2017-02-07 | Filing | |
| $2.23 | 20,000 | Officer, Director | 0 | 2016-10-21 | Filing | |
| $2.21 | 819 | Officer, Director | 0 | 2016-06-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,507,695 | $13,188,934 | 0% | |
| 2. | 2,946,552 | $11,079,036 | 0.03% | |
| 3. | 2,825,335 | $10,623,259 | 0% | |
| 4. | 1,158,808 | $4,357,605 | 0% | |
| 5. | 1,073,134 | $4,034,984 | 0% |
News See All
CorMedix Inc. (CRMD): A Bull Case Theory
We came across a bullish thesis on CorMedix Inc. (CRMD) on ValueInvesting subreddit page by gamblingPharmaStocks. In this article, we will summarize the bulls’ thesis on CRMD. CorMedix Inc.
CorMedix Inc. (NASDAQ:CRMD) Q2 2024 Earnings Call Transcript
Operator: Good day, and welcome to the CorMedix Inc. Second Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
CorMedix Inc. (NASDAQ:CRMD) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the CorMedix First Quarter 2024 Earnings Conference Call [Operator Instructions]. Today's conference call is being recorded.
CorMedix Inc. (NASDAQ:CRMD) Q4 2023 Earnings Call Transcript
CorMedix Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, expectations were $-0.21. CorMedix Inc.
CorMedix Inc. (NASDAQ:CRMD) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to CorMedix Third Quarter 2023 Earnings Conference Call. Today's call is being recorded.
CorMedix Inc. (NASDAQ:CRMD) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to CorMedix, Inc. Second Quarter 2023 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
CorMedix Inc. (NASDAQ:CRMD) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the CorMedix First Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions].
Billionaire Hedge Funds
